Concepedia

Combination Chemoimmunotherapy

Combination Chemoimmunotherapy is a therapeutic strategy in oncology that integrates cytotoxic chemotherapy with immunomodulatory agents to simultaneously eliminate tumor cells and enhance anti-tumor immune responses, thereby exploiting synergistic mechanisms to improve clinical outcomes in cancer treatment.

623

Publications

35.6K

Citations

4.9K

Authors

1.4K

Institutions

Publications per year

2017–2026

200

Parents

Publications

623

Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

Mark E. Dudley, John R. Wunderlich, James Chih‐Hsin Yang et al. · Journal of Clinical Oncology · 2005 · 1.6K citations · Full text

, , +17

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia

Michael J. Keating, Susan O’Brien, Maher Albitar et al. · Journal of Clinical Oncology · 2005 · 951 citations · Full text

, , +14

Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Tait D. Shanafelt, Xin V. Wang, Neil E. Kay et al. · New England Journal of Medicine · 2019 · 738 citations · Full text

, , +16

Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial

Kirsten Fischer, Jasmin Bahlo, Anna Maria Fink et al. · Blood · 2015 · 700 citations · Full text

, , +8

First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial

Barbara Eichhorst, Anna‐Maria Fink, Jasmin Bahlo et al. · The Lancet Oncology · 2016 · 622 citations

, , +14

1–5 of 623

Authors

4.9K

  1. MH
    Michael Hallek

    University of Cologne, Germany

    18 publications · 3.6K citations

    17

    h-index

  2. SS
    Stephan Stilgenbauer

    Universität Ulm, Germany

    16 publications · 3.6K citations

    16

    h-index

  3. KF
    Kirsten Fischer

    University Hospital Cologne, Germany

    13 publications · 2.8K citations

    13

    h-index

  4. BE
    Barbara Eichhorst

    University of Cologne, Germany

    12 publications · 2.8K citations

    12

    h-index

  5. JU
    Jordan U. Gutterman

    The University of Texas MD Anderson Cancer Center, United States

    12 publications · 664 citations

    12

    h-index

1–5 of 4.9K

Institutions

1.4K

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    28 h-index

    224 publications

    39.1K citations

  2. National Cancer Institute

    Bethesda, United States

    16 h-index

    73 publications

    36.4K citations

  3. Dana-Farber Cancer Institute

    Boston, United States

    15 h-index

    86 publications

    18.6K citations

  4. Anderson Hospital

    Cincinnati, United States

    14 h-index

    108 publications

    4.1K citations

  5. Memorial Sloan Kettering Cancer Center

    New York, United States

    14 h-index

    47 publications

    5.7K citations

  6. Roswell Park Comprehensive Cancer Center

    Buffalo, United States

    13 h-index

    25 publications

    1.4K citations

  7. The University of Texas System

    Austin, United States

    13 h-index

    107 publications

    5.3K citations

  8. The Ohio State University

    Columbus, United States

    12 h-index

    66 publications

    3.7K citations

1–8 of 1.4K

Venues

  1. PubMed

    Repository · 76 publications · 2.8K citations

    32

    h-index

  2. Journal of Clinical Oncology

    40 publications · 7.3K citations

    29

    h-index

  3. Cancer

    33 publications · 1.3K citations

    22

    h-index

  4. Blood

    26 publications · 2.3K citations

    19

    h-index

  5. Cancer Immunology Immunotherapy

    20 publications · 625 citations

    15

    h-index

1–5